Dimerix Limited (ASX:DXB)
Australia · Delayed Price · Currency is AUD 0.2500
-0.0100 (-3.85%)
Sep 10, 2026, 4:10 PM AEST
Dimerix Market Cap
Dimerix has a market cap or net worth of 150.1 million as of September 10, 2026. Its market cap has decreased by -48.96% in one year.
Market Cap
150.10M
Enterprise Value
134.18M
Revenue
6.35M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.25
ChartMarket Cap Chart
Since July 6, 2015, Dimerix's market cap has increased from 13.24M to 150.10M, an increase of 1,033.99%. That is a compound annual growth rate of 24.24%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 150.10M | -54.55% |
| Dec 31, 2025 | 330.22M | 74.10% |
| Dec 31, 2024 | 189.67M | 117.15% |
| Dec 29, 2023 | 87.35M | 87.74% |
| Dec 30, 2022 | 46.53M | -40.82% |
| Dec 31, 2021 | 78.61M | 69.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| BLS Pharmaceuticals | 260.24M |
| Actinogen Medical | 234.32M |
| Orthocell | 198.80M |
| Nyrada | 176.67M |
| Paradigm Biopharmaceuticals | 164.78M |
| Island Pharmaceuticals | 130.20M |
| Recce Pharmaceuticals | 108.55M |
| Alterity Therapeutics | 105.97M |